Combination antibiotics show promise against Drug-Resistant pneumonia
NCT ID NCT07671755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at two antibiotic treatments for ventilator-associated pneumonia caused by a multidrug-resistant bacteria. Researchers compared giving patients just colistin versus colistin plus cefoperazone-sulbactam. They measured how well patients improved clinically and on chest X-rays. The trial included 80 adults with this specific infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- colistin and cefoperazone-sulbactam
- What this could lead to
- If the combination works better, it could offer a more effective treatment option for this hard-to-treat lung infection.
- What could go wrong
- This is a small, completed study with only 80 participants, so results may not apply widely. The drugs can cause kidney or liver problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL RESPONSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Karachi, Pakistan